India asks Roche, GSK to build up bird flu drug stock.
Economic Times (New Delhi, India), December, 2005
Dec. 12--MUMBAI, India -- The government is pulling out all stops to ensure that the country is adequately prepared for a likely influenza outbreak. The government has asked GlaxoSmithKline and Roche to build up the stock of Oseltamivir, the bird flu drug.
Sources said that senior government officials in the health ministry recently met with the heads of the Indian arms of MNCs Roche and GlaxoSmithKline. According to them, the government has asked the two companies to build up stocks of their flu drugs in the country. Confirming the development, S Kalayanasundram, managing director, GSK India, said: "The government had asked the company to create its own stockpile of Relenza in India. The company has communicated this to its parent company in UK and is in the...
Most Recent Business Articles
- Multiple criteria evaluation and optimization of transportation systems
- Multi-criteria analysis procedure for sustainable mobility evaluation in urban areas
- A two-leveled multi-objective symbiotic evolutionary algorithm for the hub and spoke location problem
- Multi-criteria analysis for evaluating the impacts of intelligent speed adaptation
- The development of Taiwan arterial traffic-adaptive signal control system and its field test: a Taiwan experience
Most Recent Business Publications
Most Popular Business Articles
- 7 tips for effective listening: productive listening does not occur naturally. It requires hard work and practice - Back To Basics - effective listening is a crucial skill for internal auditors
- FAS 109: a primer for non-accountants - Financial Accounting Standards Board's "Statement 109: Accounting for Income Taxes"
- Design a commission plan that drives sales - Sales Commissions
- Too Young to Rent a Car? - 25-years-old the minimum age for car renting - Brief Article
- LIFO vs. FIFO: a return to the basics
